Cargando…
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
Autores principales: | Baird, Jason R., Feng, Zipei, Xiao, Hong D., Friedman, David, Cottam, Ben, Fox, Bernard A., Kramer, Gwen, Leidner, Rom S., Bell, R. Bryan, Young, Kristina H., Crittenden, Marka R., Gough, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813979/ https://www.ncbi.nlm.nih.gov/pubmed/29447250 http://dx.doi.org/10.1371/journal.pone.0192988 |
Ejemplares similares
-
STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2017) -
Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
por: Baird, Jason, et al.
Publicado: (2015) -
Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014) -
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021) -
Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)